Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine.

Lin, Yi-Jiun; Lin, Meei-Yun; Chuang, Ya-Shan; Liu, Luke Tzu-Chi; Kuo, Tsun-Yung; Chen, Charles; Ganesan, Shyamala; Fattom, Ali; Bitko, Vira; Lien, Chia-En

Lin, Yi-Jiun; Lin, Meei-Yun; Chuang, Ya-Shan; Liu, Luke Tzu-Chi; Kuo, Tsun-Yung; Chen, Charles; Ganesan, Shyamala; Fattom, Ali; Bitko, Vira; Lien, Chia-En.

Afiliación

Lin YJ; Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.
Lin MY; Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.
Chuang YS; Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.
Liu LT; Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.
Kuo TY; Department of Biotechnology and Animal Science, National Ilan University, Yilan County, Taiwan.
Chen C; Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.
Ganesan S; Temple University, Philadelphia, PA, 19122, USA.
Fattom A; BlueWillow Biologics, Ann Arbor, MI, 48105, USA.
Bitko V; BlueWillow Biologics, Ann Arbor, MI, 48105, USA.
Lien CE; LLC, Ann Arbor, MI, 48105, USA.

Sci Rep ; 12(1): 11369, 2022 07 05.

Article en En | MEDLINE | ID: mdl-35790783

Asunto(s)

COVID-19; Vacunas Virales; Adyuvantes Inmunológicos; Animales; Anticuerpos Antivirales; COVID-19/prevención & control; Vacunas contra la COVID-19; Cricetinae; Humanos; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google